Related Experiment Video
Updated: Jun 16, 2026
12:59
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
Disturbed regulatory T cell homeostasis in multiple sclerosis
Koen Venken1, Niels Hellings, Roland Liblau
1Hasselt University, Biomedisch Onderzoeksinstituut and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium. koen.venken@ugent.be <koen.venken@ugent.be>
Trends in Molecular Medicine
|February 18, 2010
Summary
Multiple sclerosis (MS) involves immune system dysfunction, particularly with regulatory T cells (Tregs). This review examines compromised Treg homeostasis in MS and potential therapeutic strategies.
Area of Science:
- Neuroimmunology
- Immunology
- Central Nervous System Disorders
Background:
- Multiple sclerosis (MS) is a chronic inflammatory CNS disorder with autoimmune features.
- Functional defects in CD4(+)CD25(+)FOXP3(+) regulatory T cells (Tregs) are implicated in relapsing-remitting MS.
- Recent findings show altered Treg homeostasis in MS patients.
Purpose of the Study:
- To review evidence for disturbed Treg homeostasis in MS.
- To discuss compensatory mechanisms in chronic MS.
- To highlight the importance of understanding immune regulation for Treg-based therapies.
Main Methods:
- Literature review of studies on regulatory T cells in multiple sclerosis.
- Analysis of evidence for Treg dysfunction and homeostasis alterations.
- Evaluation of potential compensatory mechanisms in chronic disease.
Main Results:
- Evidence suggests compromised Treg homeostasis in MS patients.
- Alterations observed in both naive and memory-like Tregs.
- Potential compensatory mechanisms may exist during the chronic phase of MS.
Conclusions:
- Disturbed Treg homeostasis is a significant factor in MS pathogenesis.
- Understanding Treg function is crucial for developing effective MS therapies.
- Further research into Treg-based treatments holds therapeutic promise for MS.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...